CAMLINFINE Camlin Fine Q4 FY26 results (Jan–Mar 2026) and concall
Camlin Fine Sciences reported Q4 FY26 revenue of INR 424 crores and full-year revenue of INR 1,723 crores, navigating significant geopolitical challenges that impacted sales and raw material costs. Despite these headwinds, the company saw improved vanillin realizations and strong growth in its Blends segment, targeting INR 1,400 crores for FY27. Strategic decisions like the liquidation of CFS Europe and the planned closure of the diphenol plant aim to improve profitability and cash flow, while management reaffirms its FY27 guidance.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 1.6% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 417 | 431 | 432 | 408 | 460 +10% | 441 +2% | 425 −2% |
| EBITDA | 52 | 56 | 62 | 20 | 33 −37% | 21 −62% | 21 −66% |
| Net profit | -116 | -7 | 0 | -11 | -15 +87% | -37 −429% | 86 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
